[go: up one dir, main page]

WO2001083687A3 - A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide - Google Patents

A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide Download PDF

Info

Publication number
WO2001083687A3
WO2001083687A3 PCT/CN2001/000646 CN0100646W WO0183687A3 WO 2001083687 A3 WO2001083687 A3 WO 2001083687A3 CN 0100646 W CN0100646 W CN 0100646W WO 0183687 A3 WO0183687 A3 WO 0183687A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
polynucleotide encoding
discloses
pax protein
human pax
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000646
Other languages
French (fr)
Chinese (zh)
Other versions
WO2001083687A2 (en
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU78347/01A priority Critical patent/AU7834701A/en
Publication of WO2001083687A2 publication Critical patent/WO2001083687A2/en
Publication of WO2001083687A3 publication Critical patent/WO2001083687A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention discloses a novel polypeptide, a human pax protein 23, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as malignant tumor, hemopathy, HIV infection, immunological disease, and various inflammations, etc. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the novel human pax protein 23.
PCT/CN2001/000646 2000-04-29 2001-04-28 A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide Ceased WO2001083687A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU78347/01A AU7834701A (en) 2000-04-29 2001-04-28 A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00115530A CN1321664A (en) 2000-04-29 2000-04-29 Novel polypeptide-human pax protein 23 and polynucleotide for coding this polypeptide
CN00115530.X 2000-04-29

Publications (2)

Publication Number Publication Date
WO2001083687A2 WO2001083687A2 (en) 2001-11-08
WO2001083687A3 true WO2001083687A3 (en) 2002-06-13

Family

ID=4584976

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000646 Ceased WO2001083687A2 (en) 2000-04-29 2001-04-28 A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide

Country Status (3)

Country Link
CN (1) CN1321664A (en)
AU (1) AU7834701A (en)
WO (1) WO2001083687A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002063008A2 (en) * 2001-02-08 2002-08-15 Incyte Genomics, Inc. Intracellular signaling molecules

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054344A2 (en) * 1997-05-29 1998-12-03 Creative Biomolecules, Inc. Modulators of morphogen expression and methods of identifying the same
WO1999063110A1 (en) * 1998-05-30 1999-12-09 Imperial College Innovations Limited Diagnosis and treatment of cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054344A2 (en) * 1997-05-29 1998-12-03 Creative Biomolecules, Inc. Modulators of morphogen expression and methods of identifying the same
WO1999063110A1 (en) * 1998-05-30 1999-12-09 Imperial College Innovations Limited Diagnosis and treatment of cancer

Also Published As

Publication number Publication date
AU7834701A (en) 2001-11-12
CN1321664A (en) 2001-11-14
WO2001083687A2 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
WO2001083688A3 (en) A novel polypeptide, a human subunit 13 phosphatidylinositol-4-phosphate-5-kinase ii beta and the polynucleotide encoding the polypeptide
WO2001083687A3 (en) A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide
WO2001083683A3 (en) A novel polypeptide, a human pax protein 11.3 and the polynucleotide encoding the polypeptide
WO2001083682A3 (en) A novel polypeptide, a human pax protein 11.6 and the polynucleotide encoding the polypeptide
WO2001075011A3 (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
WO2002000821A3 (en) A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide
WO2001075036A3 (en) A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide
WO2001077286A3 (en) A novel polypeptide, human uterine globine 58 and the polynucleotide encoding the polypeptide
WO2001075048A3 (en) A novel polypeptide, human ribosomal protein s11 23 and the polynucleotide encoding the polypeptide
WO2001094536A3 (en) A novel polypeptide, a human zinc-finger protein 10.89 and the polynucleotide encoding the polypeptide
WO2001094529A3 (en) A novel polypeptide, a human atp dependant serine proteinase 21 and the polynucleotide encoding the polypeptide
WO2002000828A3 (en) A novel polypeptide, a zinc-finger protein 34 and the polynucleotide encoding the polypeptide
WO2001081538A3 (en) A novel polypeptide, a human connexin 9 and the polynucleotide encoding the polypeptide
WO2001081536A3 (en) A novel polypeptide, a human ysk1 kinase protein 10, and the polynucleotide encoding the polypeptide
WO2001075034A3 (en) A novel polypeptide, human peroxydase protein 15 and the polynucleotide encoding the polypeptide
WO2001075035A3 (en) A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide
WO2001075058A3 (en) A NOVEL POLYPEPTIDE, HUMAN AMINOACYL-tRNA SYNTHETASE 15 TYPE II AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2001075039A3 (en) A novel polypeptide, human rna helicase 10 and the polynucleotide encoding the polypeptide
WO2001075016A3 (en) A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide
WO2001094534A3 (en) A novel polypeptide, a human transcription factor 9.57 and the polynucleotide encoding the polypeptide
WO2001077285A3 (en) A novel polypeptide, protein 13 of the amidase families and the polynucleotide encoding the polypeptide
WO2001094538A3 (en) A novel polypeptide, dna ligase 21 and the polynucleotide encoding the polypeptide
WO2001075057A3 (en) A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide
WO2001064866A1 (en) A novel polypeptide, a ribosome s19e protein 11 and the polynucleotide encoding the polypeptide
WO2001079431A3 (en) A novel polypeptide, a human pathway 15 protein with the huntingtine protein and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP